THE CLINICAL ANALYSIS OF SALMETEROL/FLUTICASONE PROPIONATE IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
10.3969/j.issn.1671-332X.2015.04.013
- VernacularTitle:沙美特罗／丙酸氟替卡松治疗慢性阻塞性肺疾病临床分析
- Author:
Guizhong JIANG
;
Zhiqiang XU
- Publication Type:Journal Article
- Keywords:
Salmeterol /Fluticasone propionate;
Treatment;
Chronic;
Obstructive;
Pulmonary disease;
A-nalysis
- From:
Modern Hospital
2015;(4):37-39
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical efficacy of salmeterol /fluticasone propionate in the treatment of chronic obstructive pulmonary disease .Methods 107 patients with chronic obstructive pulmonary disease from June 2012 to June 2014 were randomly divided into control group and observation group .Patients in control group re-ceived routine therapy, yet patients in observation group received salmeterol /fluticasone propionate on the basis of routine therapy.The st.George respiratory questionnaire (SGRQ) mark, 6 -minwalktest (6MWT),pulmonary func-tion indexes and drug adverse reactions before treatment and after treatment were observed respectively .Results Af-ter treatment, the lung function index recovery , the SGRQ total score,6MWT of observation group was obviously bet -ter than that of the control group , and the difference had statistical significance (p <0.05).There were no serious adverse reactions occurred in the two groups , and with no statistically significant difference (p >0.05).Conclusion On top of conventional therapy ,salmeterol /fluticasone propionate has good clinical curative effect and high safety for treating COPD,and so it is suitable for long -term and sustained treatment .
